Peritoneal cancer program at the UVM Medical Center
Peritoneal cancer is an abnormal growth of cells in the membrane that lines the abdominal cavity and covers the abdominal organs (peritoneum). This cancer can start in the peritoneum or spread there from another location.
At The University of Vermont Medical Center, we provide comprehensive peritoneal cancer care in a supportive, caring environment. Our skilled providers take a coordinated, team-based approach, working together to develop your customized treatment plan. Physicians across the region refer their patients to us for our expertise and access to advanced therapies, such as hyperthermic intraperitoneal chemotherapy (HIPEC).
As a leading cancer program in the region, we offer:
- Expert team: You receive care from a multidisciplinary team, led by board-certified surgical oncologists with deep experience in peritoneal cancers. When necessary, they work alongside medical oncologists, radiation oncologists, pathologists and radiologists who specialize in gastrointestinal cancers or gynecologic cancers. As an academic medical center, our physician-leaders are also active researchers, many of whom help train the next generation of experts.
- Personalized care: Most people with peritoneal cancer receive more than one kind of treatment. Based on your unique condition, your care team determines the most appropriate therapies, and at what point in your treatment they might offer the greatest benefit. Throughout your care journey, we monitor your progress and adjust treatment as necessary.
- Leading-edge treatments: At the UVM Cancer Center, you’ll find treatments not available elsewhere in the region. We are the only cancer program in Vermont and northern New York to offer hyperthermic intraperitoneal chemotherapy (HIPEC), which delivers a heated chemotherapy solution to the abdomen after surgery to destroy any remaining cancer cells.
